Christian Stief  European Urology Supplements 

Slides:



Advertisements
Similar presentations
Medical Management for BPH: The Role of Combination Therapy
Advertisements

Pascal Rischmann  European Urology Supplements 
Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management  Michael O’Leary  European Urology Supplements 
Management of Acute and Chronic Retention in Men
Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction  Steven A. Kaplan,
Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey  Varant Kupelian,
Shock Wave Lithotripsy for Renal and Ureteric Stones
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Shock Wave Lithotripsy for Renal and Ureteric Stones
Can Low-Intensity Extracorporeal Shockwave Therapy Improve Erectile Function? A 6- Month Follow-up Pilot Study in Patients with Organic Erectile Dysfunction 
Treatment of Advanced and Metastatic Renal Cancer: A Revolution?
Volume 52, Issue 1, Pages (July 2007)
Bladder Cancer: A Major Public Health Issue
Back to the Future: Introduction and Conclusions
Long-Term Management of Overactive Bladder with Antimuscarinic Agents
A Novel Treatment of Premature Ejaculation
Counselling the Prostate Cancer Patient
Laurent Boccon-Gibod  European Urology Supplements 
Volume 42, Issue 4, Pages (October 2002)
Volume 44, Issue 5, Pages (November 2003)
Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward?  Michel Bolla  European.
An Update of Current Practice in Hypospadias Surgery
Richard C. Harkaway  European Urology Supplements 
Volume 50, Issue 5, Pages (November 2006)
Volume 50, Issue 5, Pages (November 2006)
T. Hugh Jones  European Urology Supplements 
Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy  Bertrand Tombal, Richard Berges  European Urology.
Volume 74, Issue 5, Pages (November 2018)
Tamsulosin Oral Controlled Absorption System (OCAS) in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH):
The Importance of Testosterone Control in Prostate Cancer
What's New in Prostate Cancer: Highlights from Urologic and Oncologic Congresses in 2006  Michel Soulié, Nicolas Mottet, Laurent Salomon, Jacques Irani,
Jacques Irani  European Urology Supplements 
Optimal Testosterone Control and Eligard®
Neal Shore  European Urology Supplements 
Long-Term Hormonal Therapy: Who Would Benefit?
The Hallmarks of BPH Progression and Risk Factors
Sergio Bracarda  European Urology Supplements 
Volume 53, Issue 6, Pages (June 2008)
Pharmacotherapy in Stress and Mixed Incontinence
What are the Data on 5α-Reductase Inhibitor Treatment of Benign Prostatic Hyperplasia from Everyday Practice?  François Desgrandchamps  European Urology.
New Trends in Managing the Prostate Cancer Patient
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
Ureteropelvic Junction Obstruction
Emmanuel Chartier-Kastler, Kate Davidson  European Urology Supplements 
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Who Forms Stones and Why?
Martin Michel, Jean de la Rosette  European Urology Supplements 
How Do New Data from Clinical Trials Allow Us to Optimise the Assessment and Treatment of Patients with Benign Prostatic Hyperplasia?  Vincenzo Mirone 
The European Online Sexual Survey (EOSS): Pan-European Perspectives on the Impact of Premature Ejaculation and Treatment-Seeking Behavior  John Dean 
Richard Berges  European Urology Supplements 
Improving Flexibility and Quality of Life for Your Patients: A Must?
Profile of Silodosin European Urology Supplements
New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men
LUTS and Sexual Dysfunction: Implications for Management of BPH
The Increasing Responsibility of the Urologist in Maintaining Bone Health in Prostate Cancer Patients  Kurt Miller  European Urology Supplements  Volume.
The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study  Bob Djavan,
Prognostic Factors in Non–Muscle-Invasive Bladder Tumors
Testim® Gel: Review of Clinical Data
Cardiovascular Safety of Tamsulosin Modified Release in the Fasted and Fed State in Elderly Healthy Subjects  Martin C. Michel, Cees Korstanje, Walter.
C.G Roehrborn, T McNicholas  European Urology Supplements 
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma  Jan Roigas  European Urology Supplements  Volume.
Joaquim Bellmunt  European Urology Supplements 
Hartmut Porst  European Urology Supplements 
The Impact of Premature Ejaculation on Partners and Relationships
Oncoforum Urology: Prostate Cancer 2008 at a Glance
New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer  Noel W. Clarke  European Urology Supplements 
Jan Roigas  European Urology Supplements 
Michael Marberger  European Urology Supplements 
Appropriate Castration with Luteinising Hormone Releasing Hormone (LHRH) Agonists: What is the Optimal Level of Testosterone?  B. Tombal  European Urology.
Presentation transcript:

Testosterone and Erection: Practical Management for the Patient with Erectile Dysfunction  Christian Stief  European Urology Supplements  Volume 6, Issue 17, Pages 868-873 (November 2007) DOI: 10.1016/j.eursup.2007.08.001 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Mean sexual motivation and sexual performance scores in hypogonadal men during short-term treatment with testosterone gel or a testosterone patch [22]. European Urology Supplements 2007 6, 868-873DOI: (10.1016/j.eursup.2007.08.001) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 2 Mean sexual desire, sexual activity, and satisfaction with erection scores in hypogonadal men during long-term treatment with testosterone gel [24]. European Urology Supplements 2007 6, 868-873DOI: (10.1016/j.eursup.2007.08.001) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 3 Mean change in International Index of Erectile Function erectile dysfunction domain scores in hypogonadal men treated with sildenafil plus testosterone gel or sildenafil plus placebo [32]. European Urology Supplements 2007 6, 868-873DOI: (10.1016/j.eursup.2007.08.001) Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 4 Mean International Index of Erectile Function domain scores in hypogonadal men at baseline and after treatment with testosterone gel with or without sildenafil [35]. European Urology Supplements 2007 6, 868-873DOI: (10.1016/j.eursup.2007.08.001) Copyright © 2007 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.